![](/img/cover-not-exists.png)
A Prospective Phase I/II Trial of Bortezomib-Based Graft-Versus-Host-Disease Prophylaxis in HLA-Mismatched Unrelated Donor Reduced-Intensity Conditioning Hematopoietic Stem Cell Transplantation: Encouraging Safety, Efficacy, and Survival
J. Koreth, K.E. Stevenson, H.T. Kim, B. Bindra, S. McDonough, V.T. Ho, C.S. Cutler, P. Armand, R.J. Soiffer, J.H. Antin, J. Ritz, E.P. AlyeaVolume:
17
Year:
2011
Language:
english
Pages:
1
DOI:
10.1016/j.bbmt.2010.12.044
File:
PDF, 83 KB
english, 2011